These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8767979)

  • 1. [The efficacy of protirelin in subjects with stabilized outcomes of stroke].
    Ciffo F; Bartoli V; Puglisi E; Scebba C; Munda M; Parisi W; Murgia P
    Clin Ter; 1996 Mar; 147(3):123-9. PubMed ID: 8767979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychologic and clinical effects of protirelin tartrate in patients with stroke sequelae].
    Fioravanti M
    Ann Ital Med Int; 1990; 5(3 Pt 2):254-61. PubMed ID: 2127687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of JTP-2942, a novel thyrotropin-releasing hormone analog, on motor deficits after chronic focal cerebral ischemia in rats.
    Yonemori F; Yamaguchi T; Nakayama H; Narita K; Hojo S; Tamura A
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):74-81. PubMed ID: 10616795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protirelin tartrate. Evaluation of its effects on pyramidal-extrapyramidal rigidity in the aged during protracted treatment].
    Fonzari M; Fontanini F; Monzeglio RM; Piola P; Santiccioli L
    Clin Ter; 1991 Sep 15-30; 138(5-6):227-32. PubMed ID: 1836171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients.
    Marangell LB; George MS; Callahan AM; Ketter TA; Pazzaglia PJ; L'Herrou TA; Leverich GS; Post RM
    Arch Gen Psychiatry; 1997 Mar; 54(3):214-22. PubMed ID: 9075462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
    Qureshi AI; Kirmani JF; Sayed MA; Safdar A; Ahmed S; Ferguson R; Hershey LA; Qazi KJ;
    Neurology; 2005 Jun; 64(12):2115-20. PubMed ID: 15985583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of protirelin in schizophrenia.
    Inanaga K; Nakano T; Nagata T; Tanaka M; Ogawa N
    Arch Gen Psychiatry; 1978 Aug; 35(8):1011-4. PubMed ID: 98128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protirelin (TRH) in depression.
    Hollister LE; Berger P; Ogle FL; Arnold RC; Johnson A
    Arch Gen Psychiatry; 1974 Oct; 31(4):468-70. PubMed ID: 4214026
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral protirelin (T.R.H.) in depression.
    Sugerman AA; Swartzburg M; Mueller PS; Rochford J
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):94-8. PubMed ID: 812670
    [No Abstract]   [Full Text] [Related]  

  • 12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protirelin in the treatment of cerebrovascular disorders].
    Costa R; Cirrincione M; Chinnici M; Scaffidi A
    Clin Ter; 1990 Aug 15-31; 134(3-4):205-9. PubMed ID: 2147622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
    Cho HJ; Kim YJ
    Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The smoking-thrombolysis paradox and acute ischemic stroke.
    Ovbiagele B; Saver JL
    Neurology; 2005 Jul; 65(2):293-5. PubMed ID: 16043802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
    Brouns R; Heylen E; Sheorajpanday R; Willemse JL; Kunnen J; De Surgeloose D; Hendriks DF; De Deyn PP
    Clin Neurol Neurosurg; 2009 Feb; 111(2):165-70. PubMed ID: 18980797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Music listening enhances cognitive recovery and mood after middle cerebral artery stroke.
    Särkämö T; Tervaniemi M; Laitinen S; Forsblom A; Soinila S; Mikkonen M; Autti T; Silvennoinen HM; Erkkilä J; Laine M; Peretz I; Hietanen M
    Brain; 2008 Mar; 131(Pt 3):866-76. PubMed ID: 18287122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
    Shah SH; Liebeskind DS; Saver JL; Starkman S; Vinuela F; Duckwiler G; Jahan R; Kim D; Sanossian N; Vespa P; Ovbiagele B
    Neurology; 2006 Jun; 66(11):1745-6. PubMed ID: 16769954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
    Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
    Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.